Fidelity International’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,312,785
Closed -$129M 992
2025
Q2
$129M Buy
1,312,785
+433,785
+49% +$41M 0.11% 196
2025
Q1
$81.4M Sell
879,000
-371,000
-30% -$34.2M 0.08% 253
2024
Q4
$113M Sell
1,250,000
-59,623
-5% -$5.48M 0.11% 205
2024
Q3
$126M Buy
1,309,623
+164,548
+14% +$16.1M 0.11% 200
2024
Q2
$105M Sell
1,145,075
-161,630
-12% -$15M 0.1% 205
2024
Q1
$120M Buy
1,306,705
+1,372
+0.1% +$129K 0.12% 195
2023
Q4
$124M Buy
+1,305,333
New +$122M 0.13% 200
2022
Q2
Sell
-1,500
Closed -$258K 808
2022
Q1
$258K Sell
1,500
-41,618
-97% -$6.22M ﹤0.01% 785
2021
Q4
$6.98M Buy
+43,118
New +$6.93M 0.01% 574
2021
Q2
Sell
-11,390
Closed -$3.02M 865
2021
Q1
$3.02M Sell
11,390
-298
-3% -$84K ﹤0.01% 649
2020
Q4
$3.43M Buy
11,688
+6,373
+120% +$1.63M ﹤0.01% 580
2020
Q3
$1.26M Buy
5,315
+5,125
+2,697% +$1.17M ﹤0.01% 613
2020
Q2
$38K Buy
+190
New +$35.4K ﹤0.01% 692

Other funds holding AMED

Fidelity International's AMED Position: Q3 2025 in Review

Fidelity International sold out of Amedisys (AMED) in Q3 2025, closing a stake of 1,312,785 shares — an estimated $129M sold.

Fidelity International first reported a position in AMED in Q2 2020 and held it in 13 quarters. The position peaked at $129M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Fidelity International reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Fidelity International sold 1,312,785 Amedisys shares in Q3 2025, an estimated $129M.
  • Fidelity International first reported a position in Amedisys in Q2 2020 and held it in 13 quarters.
  • Fidelity International's Amedisys position peaked at $129M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Fidelity International's 13F filing for Q3 2025, filed 13 Nov 2025.